Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome.

Abstract	Tamoxifen, a selective estrogen receptor modulator, has been used in the treatment of peripheral precocious puberty. A 5-year and 3-month-old girl, diagnosed with McCune-Albright syndrome, came in with abnormal hair growth approximately 2 months after the initiation of tamoxifen. The pattern of terminal hair on the skin following the administration of the drug and the exclusion of other causes suggested tamoxifen-induced hirsutism.
Authors	Heves Kırmızıbekmez, Rahime Gül Yesiltepe Mutlu, Fatma Dursun, Şükriye Pınar İşgüven
Journal	Journal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 28 Issue 9-10 Pg. 1191-3 (Sep 2015) ISSN: 2191-0251 [Electronic] Germany
PMID	26024247 (Publication Type: Case Reports, Journal Article)
Chemical References	Selective Estrogen Receptor Modulators Tamoxifen
Topics	Child, Preschool Female Fibrous Dysplasia, Polyostotic (drug therapy) Hirsutism (chemically induced) Humans Selective Estrogen Receptor Modulators (adverse effects, therapeutic use) Tamoxifen (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!